Cargando…

Maternal Infection and Adverse Pregnancy Outcomes among Pregnant Travellers: Results of the International Zika Virus in Pregnancy Registry

In this multicentre cohort study, we evaluated the risks of maternal ZIKV infections and adverse pregnancy outcomes among exposed travellers compared to women living in areas with ZIKV circulation (residents). The risk of maternal infection was lower among travellers compared to residents: 25.0% (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Vouga, Manon, Pomar, Léo, Soriano-Arandes, Antoni, Rodó, Carlota, Goncé, Anna, Gratacos, Eduard, Merriam, Audrey, Eperon, Isabelle, Martinez De Tejada, Begoña, Eggel, Béatrice, Masmejan, Sophie, Rochat, Laurence, Genton, Blaise, Van Mieghem, Tim, Lambert, Véronique, Malvy, Denis, Gérardin, Patrick, Baud, David, Panchaud, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926842/
https://www.ncbi.nlm.nih.gov/pubmed/33671742
http://dx.doi.org/10.3390/v13020341
Descripción
Sumario:In this multicentre cohort study, we evaluated the risks of maternal ZIKV infections and adverse pregnancy outcomes among exposed travellers compared to women living in areas with ZIKV circulation (residents). The risk of maternal infection was lower among travellers compared to residents: 25.0% (n = 36/144) versus 42.9% (n = 309/721); aRR 0.6; 95% CI 0.5–0.8. Risk factors associated with maternal infection among travellers were travelling during the epidemic period (i.e., June 2015 to December 2016) (aOR 29.4; 95% CI 3.7–228.1), travelling to the Caribbean Islands (aOR 3.2; 95% CI 1.2–8.7) and stay duration >2 weeks (aOR 8.7; 95% CI 1.1–71.5). Adverse pregnancy outcomes were observed in 8.3% (n = 3/36) of infected travellers and 12.7% (n = 39/309) of infected residents. Overall, the risk of maternal infections is lower among travellers compared to residents and related to the presence of ongoing outbreaks and stay duration, with stays <2 weeks associated with minimal risk in the absence of ongoing outbreaks.